ResearcherUniversity of GlasgowNo recent work listed

Oliver D.K. Maddocks

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5551-9091; OpenAlex author ID A5074382164. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper

Papers 3

Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells. Last author DOI 10.1016/j.molcel.2021.03.019 ↗
The KRAS-BCAA-BCAT2 axis in PDAC development First author DOI 10.1038/s41556-020-0467-2 ↗
The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis. Co-author DOI 10.1038/s42255-019-0159-z ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mattia Falcone · 2 shared papers, 2020–2021 · strength 0.37
- Paper The KRAS-BCAA-BCAT2 axis in PDAC development DOI 10.1038/s41556-020-0467-2 ↗
- Paper Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate … DOI 10.1016/j.molcel.2021.03.019 ↗
Alice C. Newman · 1 shared paper, 2021 · strength 0.13
- Paper Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate … DOI 10.1016/j.molcel.2021.03.019 ↗
Amélie Juin · 1 shared paper, 2020 · strength 0.12
- Paper The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis. DOI 10.1038/s42255-019-0159-z ↗
Vassilis Papalazarou · 1 shared paper, 2020 · strength 0.12
- Paper The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis. DOI 10.1038/s42255-019-0159-z ↗
Laura M. Machesky · 1 shared paper, 2020 · strength 0.12
- Paper The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis. DOI 10.1038/s42255-019-0159-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.